A business plan for a robotic neurosurgical device invented by Vanderbilt University engineers won top honors last week at the sixth annual TechVenture Challenge.

Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14.

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

Robert Lefkowitz, M.D., who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on March 31.

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 12th annual Research Staff Awards luncheon at the University Club.